Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents

Overview of attention for article published in Clinical Gastroenterology and Hepatology, August 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter: 14 X users
facebook: 2 Facebook pages

guideline: 3 clinical guideline sources

Readers on

mendeley: 96 Mendeley

So far, Altmetric has seen 18 X posts from 14 X users, with an upper bound of 60,152 followers.

RT @DrJordanAxelrad: @DCharabaty @MondayNightIBD @JeanFredericCo1 @JeanDonet @DrHarryThomas @AdamEhrlichMD @Jonathansegal85 @ibdseb @charli…

@DCharabaty @MondayNightIBD @JeanFredericCo1 @JeanDonet @DrHarryThomas @AdamEhrlichMD @Jonathansegal85 @ibdseb @charlie_lees @IBDCedarsSinai @DavidHudesmanMD @GIDrHwang @tinahamd @PeyrinBiroulet @peter_bossuyt @J_Kirchgesner @MLongMD @ryanungaro @fgomol…

@LanceShaver Not my area of expertise but here are a few refs. Note that most studies have been observational or retrospective. Would recommend discussing w pt’s oncologist if possible. https://t.co/HChjioobfo https://t.co/Oxb23jHS9x https://t.co/qpl…

RT @DrJordanAxelrad: @ibdgijami @MondayNightIBD Data sparse but our #NYCCO study showed no risk with anti-TNF: https://t.co/mPA65btaYq Anot…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 14 additional X posts.